References
- Ashizawa T, Okada R, Suzuki Y, et al (2005). Clinical significance of interleukin-6 (IL-6) in the spread of gastric cancer: role of IL-6 as a prognostic factor. Gastric Cancer, 8, 124-31. https://doi.org/10.1007/s10120-005-0315-x
- Atherton JC (2006). The pathogenesis of Helicobacter pyloriinduced gastro-duodenal diseases. Ann Rev Pathol, 1, 63-96. https://doi.org/10.1146/annurev.pathol.1.110304.100125
- Bauer J, Ganter U, Geiger T, et al (1988). Regulation of interleukin-6 expression in cultured human blood monocytes and monocyte-derived macrophages. Blood, 72, 1134-40.
- Chen HF, Mai JR, Wan JX, et al (2013). Role of a novel functional variant in the PPP2R1A promoter on the regulation of PP2A-Aalpha and the risk of hepatocellular carcinoma. PLoS One, 8, e59574. https://doi.org/10.1371/journal.pone.0059574
- Crabtree JE, Shallcross TM, Heatley RV, et al (1991). Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut, 32, 1473-7. https://doi.org/10.1136/gut.32.12.1473
- Gong YH, Sun LP, Jin SG, et al (2010). Comparative study of serology and histology based detection of Helicobacter pylori infections: a large population-based study of 7, 241 subjects from China. Eur J Clin Microbiol Infect Dis, 29, 907-11. https://doi.org/10.1007/s10096-010-0944-9
- He J, Qiu LX, Wang MY, et al (2012). Polymorphisms in the XPG gene and risk of gastric cancer in Chinese populations. Hum Genet, 131, 1235-44. https://doi.org/10.1007/s00439-012-1152-8
- Jarnicki A, Putoczki T, Ernst M (2010). Stat3: linking inflammation to epithelial cancer - more than a “gut” feeling? Cell Div, 5, 14. https://doi.org/10.1186/1747-1028-5-14
- Liao WC, Lin JT, Wu CY, et al (2008). Serum interleukin-6 level but not genotype predicts survival after resection in stages II and III gastric carcinoma. Clin Cancer Res, 14, 428-34. https://doi.org/10.1158/1078-0432.CCR-07-1032
- Ponder BA (2001). Cancer genetics. Nature, 411, 336-41. https://doi.org/10.1038/35077207
- Sipponen P (2002). Gastric cancer: pathogenesis, risks, and prevention. J Gastroenterol, 37, 39-44. https://doi.org/10.1007/BF02990098
- Sipponen P, Marshall BJ (2000). Gastritis and gastric cancer. Western countries. Gastroenterol Clin North Am, 29, 579-92, v-vi. https://doi.org/10.1016/S0889-8553(05)70131-X
- Smith AJ, D'Aiuto F, Palmen J, et al (2008). Association of serum interleukin-6 concentration with a functional IL6 -6331T>C polymorphism. Clin Chem, 54, 841-50. https://doi.org/10.1373/clinchem.2007.098608
- Sugimoto M, Yamaoka Y, Furuta T (2010). Influence of interleukin polymorphisms on development of gastric cancer and peptic ulcer. World J Gastroenterol, 16, 1188-200. https://doi.org/10.3748/wjg.v16.i10.1188
- Waldner MJ, Foersch S, Neurath MF (2012). Interleukin-6--a key regulator of colorectal cancer development. Int J Biol Sci, 8, 1248-53. https://doi.org/10.7150/ijbs.4614
- Wang J, He W, Liu J, et al (2012). Association of IL-6 polymorphisms with gastric cancer risk: evidences from a meta-analysis. Cytokine, 59, 176-83. https://doi.org/10.1016/j.cyto.2012.03.032
- Yang L, Li Y, Ling X, et al (2011). A common genetic variant (97906C>A) of DAB2IP/AIP1 is associated with an increased risk and early onset of lung cancer in Chinese males. PLoS One, 6, e26944. https://doi.org/10.1371/journal.pone.0026944
- Yin YW, Sun QQ, Hu AM, et al (2012). Associations between interleukin-6 gene -174 C/G and -572 C/G polymorphisms and the risk of gastric cancer: a meta-analysis. J Surg Oncol, 106, 987-93. https://doi.org/10.1002/jso.23199
- Yu H, Pardoll D, Jove R (2009). STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer, 9, 798-809. https://doi.org/10.1038/nrc2734
- Yu J, Jia Y, Cheung KF, et al (2011). Polymorphisms in interleukin-6-6331 influences the susceptibility of a Chinese population to gastric cancer. Cancer Invest, 29, 564-72. https://doi.org/10.3109/07357907.2011.605411
- Yuzhalin A (2011). The role of interleukin DNA polymorphisms in gastric cancer. Hum Immunol, 72, 1128-36. https://doi.org/10.1016/j.humimm.2011.08.003
Cited by
- Influence of Propofol, Isoflurane and Enflurance on Levels of Serum Interleukin-8 and Interleukin-10 in Cancer Patients vol.15, pp.16, 2014, https://doi.org/10.7314/APJCP.2014.15.16.6703
- Pemetrexed is Mildly Active with Good Tolerability in Treating Patients with Gastric Cancer vol.15, pp.17, 2014, https://doi.org/10.7314/APJCP.2014.15.17.7137
- IL-1β Polymorphism and Expression Associated with Decreased Risk of Gastric Carcinoma: a Case Control Study in the Ethnic Kashmiri Population, India vol.16, pp.5, 2015, https://doi.org/10.7314/APJCP.2015.16.5.1987
- mitotic checkpoint genes contribute to gastric cancer susceptibility vol.58, pp.9, 2017, https://doi.org/10.1002/em.22129